Which has the lower trailing P/E, KMDA or PBYI?

PBYI has the lower trailing P/E: KMDA trades at 21.62 and PBYI at 18.55. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, KMDA or PBYI?

Over the past five years, KMDA grew revenue faster — KMDA at a 10.59% CAGR versus PBYI at 0.29%.

Does KMDA or PBYI pay a bigger dividend?

KMDA pays a dividend (5.25% yield), while PBYI has no payments in the available dividend history.

How have KMDA and PBYI total returns compared?

Over the past 10 years, KMDA delivered 5.44% and PBYI delivered -17.43% annualized total return. Past performance doesn't predict future results.

Kamada Ltd. (KMDA) vs Puma Biotechnology, Inc. (PBYI)

A side-by-side comparison of Kamada Ltd. and Puma Biotechnology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

KMDA

Kamada Ltd.

$473M

$8.19HealthcareDelayed quote: Oct 6, 2026, 12:13 PM EDT

PBYI

Puma Biotechnology, Inc.

$487M

$9.58HealthcareDelayed quote: Oct 6, 2026, 12:14 PM EDT

Total return — KMDA vs PBYI

growth of $100 · dividends reinvested · last 10y

KMDA +68.8% (+5.4%/yr)PBYI -85.3% (-17.4%/yr)KMDA compounded faster over this window

Log scale — wide-divergence pair

KMDA PBYI

KMDA vs PBYI: by the numbers

•PBYI is the larger company ($487M vs $473M market cap).
•PBYI trades at the lower trailing earnings multiple (18.55 vs 21.62 P/E), one valuation lens rather than an overall verdict.
•KMDA grew revenue faster over the past five years (10.59% vs 0.29% CAGR).
•KMDA pays a dividend (5.25% yield), while PBYI has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	KMDA	PBYI
P/E ratio	21.62	18.55
Forward P/E	17.16	25.20
P/S ratio	2.46	2.11
P/B ratio	1.75	3.52
EV / EBITDA	10.55	10.50
FCF yield	5.60%	8.43%

Profitability

Metric	KMDA	PBYI
Gross margin	40.82%	74.83%
Operating margin	14.51%	13.16%
Net margin	11.60%	11.55%
ROE	8.25%	19.28%
ROIC	6.95%	18.26%

Dividends

Metric	KMDA	PBYI
Dividend yield	5.25%	N/A
Payout ratio	110.82%	N/A

Growth (annualized)

Metric	KMDA	PBYI
Revenue CAGR (5Y)	10.59%	0.29%
EPS CAGR (5Y)	-1.98%	N/A
FCF CAGR (5Y)	40.37%	90.51%
Total return CAGR (5Y)	10.36%	9.26%

Frequently asked

Which has the lower trailing P/E, KMDA or PBYI?: PBYI has the lower trailing P/E: KMDA trades at 21.62 and PBYI at 18.55. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, KMDA or PBYI?: Over the past five years, KMDA grew revenue faster — KMDA at a 10.59% CAGR versus PBYI at 0.29%.
Does KMDA or PBYI pay a bigger dividend?: KMDA pays a dividend (5.25% yield), while PBYI has no payments in the available dividend history.
How have KMDA and PBYI total returns compared?: Over the past 10 years, KMDA delivered 5.44% and PBYI delivered -17.43% annualized total return. Past performance doesn't predict future results.

Go deeper

Full KMDA analysis Full PBYI analysis Interactive comparison tool

Dig into the metrics

Kamada P/E ratio Puma Biotechnology P/E ratio Kamada dividend yield Kamada ROE Puma Biotechnology ROE Kamada operating margin Puma Biotechnology operating margin Kamada revenue growth Puma Biotechnology revenue growth Kamada free cash flow Puma Biotechnology free cash flow

Kamada & Puma Biotechnology appear in these rankings

Highest Dividend Yield Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.